HOMOCYSTEINE AND HLA B27-ASSOCIATED ARTHROPATHIES

HOMOCYSTEINE AND HLA B27-ASSOCIATED ARTHROPATHIES

Bibliographic Details
Main Authors:	Gao, X, Wordsworth, P, Mcmichael, A, Taurog, J, Dougan, G
Format:	Journal article
Published:	1995

Similar Items

Homocysteine modification of HLA antigens and its immunological consequences.
by: Gao, X, et al.
Published: (1996)

Genotyping HLA-B27 in spondyloarthropathies.
by: Brown, M, et al.
Published: (1998)

The role of HLA-B27 in spondyloarthritis.
by: Allen, R, et al.
Published: (1999)

HLA class I typing by PCR: HLA-B27 and an African B27 subtype.
by: Hill, A, et al.
Published: (1991)

HLA-B27-RESTRICTED PEPTIDE PRESENTATION TO CYTOTOXIC T-CELLS IN REACTIVE ARTHRITIS
by: Bowness, P, et al.
Published: (1995)

ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients.
by: Robinson, P, et al.
Published: (2015)

HLA-B associations of HLA-B27 negative ankylosing spondylitis: comment on the article by Yamaguchi et al.
by: Brown, M, et al.
Published: (1996)

Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.
by: Huet, S, et al.
Published: (1990)

HLA-B27 transgenic rodents express cell surface HLA-B27 heavy chain homodimers and multimers.
by: Bowness, P, et al.
Published: (2003)

HLA-B27: natural function and pathogenic role in spondyloarthritis.
by: McMichael, A, et al.
Published: (2002)

Functional characterisation of HLA-B27 in autoimmunity
by: Kollnberger, S, et al.
Published: (2001)

Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease.
by: Orchard, T, et al.
Published: (2000)

Immunogenetics and rheumatic diseases: 25 years on from HLA-B27
by: Wordsworth, P
Published: (1999)

Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue
by: Rysnik, O, et al.
Published: (2016)

HLA-B27
by: Bowness, P
Published: (2015)

PATTERNS OF SKIN DISEASE IN PSORIATIC ARTHRITIS AND ASSOCIATIONS WITH HLA-B27
by: Williamson, L, et al.
Published: (2002)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
by: Wong-Baeza, I, et al.
Published: (2011)

HLA genes are important phenotype determining genes in the peripheral arthropathies of inflammatory bowel disease (IBD).
by: Orchard, T, et al.
Published: (1998)

Identification and characterisation of cell surface HLA-B27 homodimers
by: Bird, L, et al.
Published: (2002)

Genes of the HLA region are important in determining clinical phenotype in the peripheral arthropathies of inflammatory bowel disease (IBD).
by: Orchard, T, et al.
Published: (1998)

Expression and function of HLA-B27 in lipid-linked form: implications for cytotoxic T lymphocyte-induced apoptosis signal transduction.
by: Gao, X, et al.
Published: (1993)

Data showing non-conventional HLA-B27 expression in axial joints and gut tissue from B27 transgenic rats, and in frozen and paraffin-fixed synovial SpA tissue
by: Rysnik, O, et al.
Published: (2016)

Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides
by: Yang, X, et al.
Published: (2022)

Genetic modulation of antigen presentation by HLA-B27 molecules.
by: Pazmany, L, et al.
Published: (1992)

Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases.
by: Kuon, W, et al.
Published: (2001)

HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
by: Kollnberger, S, et al.
Published: (2004)

Ankylosing spondylitis: evidence for a non-HLA-B*27 protective effect - Reply
by: Brown, M, et al.
Published: (1998)

The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn's disease.
by: Orchard, T, et al.
Published: (2009)

Dimers are forever. Expression and recognition of abnormal HLA-B27 in spondylo arthritis
by: Bowness, P, et al.
Published: (2005)

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
by: Evans, D, et al.
Published: (2011)

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility
by: Evans, D, et al.
Published: (2011)

Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27.
by: Bowness, P, et al.
Published: (1994)

Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.
by: Kollnberger, S, et al.
Published: (2007)

Ankylosing spondylitis (AS) in inflammatory bowel disease (IBD) is associated with possession of HLA-B27 and DR1
by: Orchard, T, et al.
Published: (1997)

EXPRESSION OF HLA-B27 HEAVY CHAIN FORMS IN ANKYLOSING SPONDYLITIS AND HLA-B27 POSITIVE CELL LINES
by: Rysnik, O, et al.
Published: (2012)

Jekyll and Hyde: the transformation of HLA-B27.
by: Edwards, J, et al.
Published: (2000)

Ankylosing spondylitis in west Africans - evidence for a non-HLA-B*27 protective effect - reply
by: Brown, M, et al.
Published: (1997)

HLA-B*27 is associated with CNO in a European cohort
by: Daire O’Leary, et al.
Published: (2023-06-01)

Cell-surface expression and immune receptor recognition of HLA-B27 homodimers.
by: Kollnberger, S, et al.
Published: (2002)

IDENTIFICATION OF T-CELL RECEPTOR RECOGNITION RESIDUES FOR AN INFLUENZA-VIRUS NONAMER PEPTIDE EPITOPE PRESENTED BY HLA B27
by: Bowness, P, et al.
Published: (1995)